Citation

John S. Lambert, M.D., Mindell Seidlin, M.D., Richard C. Reichman, M.D., Carol S. Plank, R.N., Maura Laverty, R.N., Gene D. Morse, Pharm.D., Catherine Knupp, D.V.M., Colin McLaren, Ph.D., Carla Pettinelli, M.D., Ph.D., Fred T. Valentine, M.D., Raphael Dolin, M.D. 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial. New England Journal of Medicine. 1990 May 10; 322(19):1333-40.

Citation

Brendan Larder, Ph.D., Bruce Chesebro, Douglas D. Richman, M.D. Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay. Antimicrobial Agents and Chemotherapy. 1990 Mar 01; 34(3):436-41.

Citation

Ronald T. Mitsuyasu, M.D. Hematopoietic growth factors in the treatment of patients with HIV infection. Biotherapy. 1990 Jan 01; 2(2):173-81.

Citation

James R. Munis, Douglas D. Richman, M.D., Richard S. Kornbluth. Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction by lipopolysaccharide. Journal of Clinical Investigation. 1990 Feb 01; 85(2):591-6.

Citation

S. Peglow, Alan G. Smulian, Michael J. Linke, C. L. Pogue, John P. Phair, M.D., Jonathan W. M. Gold, M.D., Daniel Armstrong, Ph.D., Peter D. Walzer, M.D. Serologic responses to Pneumocystis carinii antigens in health and disease. Journal of Infectious Diseases. 1990 Feb 01; 161(2):296-306.

Citation

Douglas D. Richman, M.D. Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus. American Journal of Medicine. 1990 May 21; 88(Suppl 5B):8S-10S.

Citation

Fred Richard Sattler, M.D., Carmen Joseph Allegra, M.D., Thomas D. Verdegem, Bisher Akil, M.D., Carmelita U. Tuazon, M.D., Claire Hughlett, Debra M. Ogata-Arakaki, R.N., Judith Feinberg, M.D., James Shelhamer, M.D., H. Clifford Lane, M.D., Roger Davis, C. Thomas Boylen, John M. Leedom, M.D., Henry Masur, M.D. Trimetrexate-leucovorin dosage evaluation study for treatment of pneumocystis carinii pneumonia. Journal of Infectious Diseases. 1990 Jan 01; 161(1):91-6.

Citation

Greg Spear, Ph.D., Alan Landay, Ph.D., Brenda L. Sullivan, B. Dittel, T. F. Lint. Activation of complement on the surface of cells infected by human immunodeficiency virus. Journal of Immunology. 1990 Feb 15; 144(4):1490-6.

Citation

Jashvant D. Unadkat, Ph.D., Ann C. Collier, M.D., Dana Cummings, A.R.N.P., Kent Opheim, Lawrence Corey, M.D. Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal. AIDS. 1990 Mar 01; 4(3):229-32.

Citation

Paul Volberding, M.D., Stephen W. Lagakos, Ph.D., Matthew A. Koch, M.D., Carla Pettinelli, M.D., Ph.D., Maureen Myers, Ph.D., David K. Booth, P.A., Henry H. Balfour, Jr., M.D., Richard C. Reichman, M.D., John Alexander Bartlett, M.D., Martin S. Hirsch, M.D., Robert L. Murphy, M.D., W. David Hardy, M.D., Ruy Soeiro, M.D., Margaret A. Fischl, M.D., John G. Bartlett, M.D., Thomas C. Merigan, Jr., M.D., Newton E. Hyslop, Jr., M.D., Douglas D. Richman, M.D., Fred T. Valentine, M.D., Lawrence Corey, M.D. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. New England Journal of Medicine. 1990 Apr 05; 322(14):941-9.